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AbstrACt
Objectives To explore patient views and perspectives 
of current management of chronic rhinosinusitis (CRS) in 
primary and secondary care.
Design Semistructured qualitative telephone interviews 
as part of the MACRO programme (Defining best 
Management for Adults with Chronic RhinOsinusitis).
setting Primary care and secondary care ear, nose and 
throat outpatient clinics in the UK.
Participants Twenty-five patients consented to in-
depth telephone interviews. Transcribed recordings 
were managed using NVivo software and analysed using 
inductive thematic analysis.
results CRS has a significant impact on patients’ 
quality of life, affecting their ability to work effectively, 
their social interactions and daily living. Patients seek 
help when symptoms become unmanageable, but can 
become frustrated with the primary care system with 
difficulties obtaining an appointment, and lack of continuity 
of care. Patients perceive that general practitioners can 
be dismissive of CRS symptoms, and patients often 
prioritise other concerns when they consult. Health system 
barriers and poor communication can result in delays in 
accessing appropriate treatment and referral. Adherence to 
intranasal steroids is a problem and patients are uncertain 
about correct technique. Nasal irrigation can be time-
consuming and difficult for patients to use. Secondary 
care consultations can appear rushed, and patients would 
like specialists to take a more ‘holistic’ approach to their 
management. Surgery is often considered a temporary 
solution, appropriate when medical options have been 
explored.
Conclusions Patients are frustrated with the management 
of their CRS, and poor communication can result in delays in 
receiving appropriate treatment and timely referral. Patients 
seek better understanding of their condition and guidance to 
support treatments decisions in light of uncertainties around 
the different medical and surgical options. Better coordinated 
care between general practice and specialist settings and 
consistency of advice has the potential to increase patient 
satisfaction and improve outcomes.
IntrODuCtIOn 
Chronic rhinosinusitis (CRS) is a prevalent 
inflammatory condition of the mucosa of the 
nose and paranasal sinuses, in the presence 
(CRSwNP) or absence (CRSsNP) of nasal 
polyps. Prevalence rates are approximately 
10% in the UK1 and data from the Clinical 
Practice Research Datalink estimate that 1% 
of UK adults receive treatment annually in 
primary care.2 With an estimated 120 000 
outpatient consultations and 40 000 sinus 
operations per year in England and Wales,3 
CRS contributes a significant burden to 
National Health Service healthcare resources.
Patients with CRS typically report symp-
toms of nasal congestion, nasal discharge, 
facial pain/pressure and anosmia which can 
have a significant effect on health-related 
quality of life.4 5 Research has found the 
impact of CRS to be equal to or greater than 
other chronic diseases such as congestive 
heart failure, angina and chronic obstructive 
pulmonary disease,4 and the extent of impact 
has been found to affect patient CRS treat-
ment decisions.6
Treatment for CRS may include self-man-
agement techniques, topical and oral 
strengths and limitations of this study
 ► The interviews permitted exploration of patient 
views of living with chronic rhinosinusitis (CRS) and 
helped to understand the treatment pathway from 
the CRS patient perspective.
 ► The study included patients from both primary, sec-
ondary and tertiary care, representing the views of 
patients at different stages of their CRS journey.
 ► It is unclear whether our sample of patients was 
similar in characteristics to the non-responders. It is 
possible that our primary care sample represents a 
group of patients with more severe or troublesome 
CRS symptoms.
 ► The views and experiences of the healthcare pro-
fessionals responsible for the patient care are not 
included but are presented elsewhere.
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medical treatments and surgery. However, patient 
expectations and experiences of CRS management 
have yet to be fully explored. Preliminary qualita-
tive research identified patients’ frustration with 
inadequate treatment and lack of coordinated care7; 
hence, further work is required to better understand 
the patient pathway in terms of patient–practitioner 
interactions, decision-making for treatments and 
indication for referral. There may also be differing 
views between healthcare professionals and patients 
regarding the severity and impact of sinus disease8 
which needs exploring in light of its potential effect 
on the patient pathway.
This paper reports a qualitative interview study 
exploring CRS patients’ views and experiences of living 
with CRS and aims to understand the treatment pathway 
from the patient perspective. Views and experiences of 
general practitioners (GPs) and ears, nose and throat 
(ENT) specialists are also explored as part of this work 
but presented elsewhere.9 This study is part of the wider 
National Institute of Health Research supported MACRO 
programme (Defining best Management for Adults with 
Chronic Rhinosinusitis)10 which aims to define best prac-
tice for treating and managing patients with CRS.
MethODs
Design
A qualitative interview study with a purposive sample of 
primary care and secondary care patients with CRS.
Participants and procedures
Patients with CRS were recruited through general prac-
tice and ENT clinics in the UK between January and 
April 2017. GP practices were purposefully selected 
based on practice demographics and geographical 
location to include rural and urban practices in the 
south and east of England. ENT clinics were recruited 
in similar geographical locations to identify patients 
who had experience of secondary care management 
in the same regions.
Primary care patients with a documented diagnosis of 
CRS were identified using a search of electronic primary 
care medical records. One hundred and five patients 
from three general practices were sent a study pack 
containing an invitation letter and information sheet, and 
27 expressed their interest by returning a reply slip to the 
research team. Additionally, 23 secondary care patients 
with a diagnosis of CRS according to the European Posi-
tion Paper on Rhinosinusitis and Nasal Polyps (EPOS) 
guidelines11 from two ENT clinics were given a study pack 
during their consultation which resulted in a further 12 
patients expressing interest in taking part. The reply slip 
also asked patients to rate how problematic their CRS 
symptoms were using a visual analogue scale ranging 
from 0 (not a problem) to 10 (worst thinkable). Patients 
were purposefully sampled to take part in a research 
interview using a range of characteristics including age, 
gender, severity of CRS symptoms, symptom duration, 
self-reported polyp status and previous sinus surgery.
Interviews
Semistructured interviews were conducted by a trained 
interviewer (JV), each lasting approximately 25–55 min. 
JV (female) is a trained qualitative research fellow for 
the MACRO programme, who was not previously known 
to the respondents. Interviews were conducted by tele-
phone to facilitate the inclusion of patients from a wide 
geographical area. An interview guide was developed 
through discussions with the wider MACRO Programme 
research team and piloted with a patient contributor (IS) 
(see online supplementary appendix 1). The guide was 
used to structure the interview but remained sufficiently 
flexible to explore unforeseen topics and concerns. 
Field notes were made during the interview to facilitate 
interpretation and contextualisation of the interview 
data. Verbal consent was given by each patient prior to 
commencing the interview.
Patients were asked to describe their experiences of 
CRS, explain how they sought help and treatment and 
describe their experiences of different treatment options 
available in primary and secondary care. The interviews 
were audio-recorded and transcribed verbatim in prepa-
ration for analysis. We took a pragmatic approach to 
research design and methods, and our epistemological 
position was one of subtle realism.12 New participant 
interviews continued until data saturation was achieved, 
that is, no new themes were emerging.
Analysis
Data management was facilitated through the use of 
NVivo V.11 qualitative analysis software, and inductive 
thematic analysis13 was used to analyse the transcribed 
data. The analytical process commenced with familiarisa-
tion and immersion in the data itself, by both rereading 
transcripts, listening back to the recorded interviews and 
reviewing the field notes. Initial ideas and concepts were 
noted. Sections of the data were then systematically coded 
using descriptive labels. Coding decisions were discussed 
at an early stage with another member of the MACRO 
team (CE). This brought an additional perspective to the 
analysis and provided the opportunity to settle uncer-
tainties and reach agreement. Codes were then merged, 
grouped together, refined and relabelled resulting in a 
set of themes and subthemes which systematically and 
thoroughly explained the data. Data collection and anal-
ysis took place concurrently, and interviews continued 
until no new themes were emerging and thematic data 
saturation was achieved.
Patient involvement
A patient contributor from the MACRO programme 
management group provided input into the design of the 
study and contributed to the development of the interview 
topic guide. A second patient contributor (IS) helped to 
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pilot the interview guide and reviewed and commented 
on drafts of this manuscript.
results
Participants
A total of 25 patients participated in a telephone inter-
view. The median age was 49 years (range 20–74) and 14 
(56%) were male. Included participants had a median 
history of CRS of 10 years (range 1–40); 56% of partic-
ipants reported being diagnosed with nasal polyps 
(CRSwNP) and 40% reported previous sinus surgery. 
Patient characteristics are presented in table 1.
themes
Thematic analysis identified four main themes relating 
to patient views and experiences of CRS management 
(table 2). Quotations are presented to illustrate the 
themes and subthemes, with details of the participants 
presented in parentheses.
Theme 1: recognising impact
Living with CRS
CRS was commonly described as annoying and frustrating 
for participants, especially if their symptoms adversely 
affect their daily life. Others report feeling depressed, sad 
and upset about their condition, which in turn can result 
in a feeling of lack of confidence.
I think the worst thing about it overall is if you don’t 
keep on top of it, it can be amazingly depressing. 
(P25, male, CRSwNP)
Many participants described feeling embarrassed and 
self-conscious about their condition, especially when 
constant nasal discharge or nasal congestion affects ability 
to speak clearly in social or work situations.
In my job I have to talk to people and obviously when 
I have a blocked nose my words are not so clear. I’m 
a lecturer so I have to speak in front of students, it’s 
uncomfortable. (P16, male, CRSwNP)
Impact on work and social life
Poor or disrupted sleep associated with CRS was 
commonly reported, leading to tiredness and fatigue, and 
consequently affecting ability to concentrate and be fully 
effective at work.
It’s more like actually in my nose and up to the eye-
brow area, but then it’s also just mainly fatigue as well, 
that’s a big part, feeling completely drained. (P20, 
female,CRSsNP)
Participants with a loss of smell and taste often reported 
reduced enjoyment in socialising and eating out.
Eating food was a necessity, not a nicety because there 
was no real pleasure. I could order the best steak on 
the menu, but I didn’t have a scooby doo of whether 
it tasted it good or not. (P25, male, CRSwNP)
Table 1 Participant characteristics
n=25
Male 14
Female 11
Age (median, range) 50 (20–74)
Ethnicity
  White British 22
  White Latin American 1
  Black African 1
  Asian 1
Deprivation score (proxy measure using 
postcodes)
6.5 (3–10)
Recruited via primary care (National Health 
Service [NHS] trust/practice location)
n=17
  NHS Cambridgeshire/rural village 9
  NHS Lewisham/urban-major conurbation 2
  NHS Southampton/urban city and town 6
Recruited via secondary care n=8
  Salisbury NHS Foundation Trust/urban city 
and town
1
  James Paget University Hospital NHS 
Foundation Trust/rural town and fringe
7
Severity of chronic rhinosinusitis (CRS) (visual 
analogue scale 0–10) (mean,range)
7 (3–10)
Time with CRS (years) (median, range) 10 (1–40)
Nasal polyps (patient report)
  With nasal polyps (CRSwNP) 14
  Without nasal polyps (CRSsNP) 11
Previous secondary care consultation
  Yes 21
  No 4
Previous sinus surgery
  Yes 10
  No 15
Table 2 Themes and subthemes of the analysis
Themes Subthemes
1. Recognising impact Living with chronic rhinosinusitis 
Impact on work and social life
Accepting and normalising
2. Seeking resolution Self-managing symptoms
Medical treatment options
3. Healthcare interactions Primary care consultation
Expectations of secondary care
4. Surgical intervention When surgery is acceptable
Decision-making for surgery
Anticipated outcomes
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Others expressed concerns about potential risks and 
hazards of being unable to smell, especially being unable 
to detect gas leaks, burning or perished food.
There’s also a danger element as well, you know, if 
something’s burning, I cannot smell it so that’s quite 
important for me. (P10, male, CRSsNP)
Accepting and normalising
Participants discussed ways of learning to live with the 
symptoms of CRS, describing it as just becoming part of 
their normal lives. Others described forgetting what it was 
like to be ‘normal’, or report moving to a ‘new normal’ of 
accepting that they are no longer able to smell.
I mean, I lost my sense of smell eight, nine years ago, 
so it’s sort of - I’ve lived with it for a long time, and at 
the end of the day, I end up living with it. (P2, male, 
CRSwNP)
Participants described how they adapted to life with 
CRS, including always being prepared for symptoms 
to occur and taking preventative measures to reduce 
symptoms.
I can never leave the house without tissues, hankies, 
I’ve always got them, even in the summer time. (P11, 
female, CRSsNP)
Others with a loss of smell and taste described ways of 
managing their symptoms to prevent judgement by other 
people.
I have customers [as a waitress] that do ask me, ‘What 
does that taste like?’ I have to almost lie, … I’m trying 
to learn and get to the stage where is it better to just 
pretend I can smell and taste. (P24, female, CRSsNP)
Theme 2: seeking resolution
Self-managing symptoms
A number of methods for self-managing their CRS symp-
toms were reported by participants. Some use steam 
inhalation during acute exacerbations, often adding 
herbs and oils to clear congestion and sooth facial pain 
and pressure, although several expressed doubt about its 
effectiveness.
I find that helpful. It does relieve certainly the pain. 
My nose just streams. It’s like I’ve got a stream com-
ing out of my nose but it does relieve the pain. (P17, 
female, CRSsNP)
The use of over-the-counter medical treatments such as 
decongestants, pain relief and nasal sprays for symptom 
management was commonly reported with mixed results. 
Some participants sought relief with complementary ther-
apies such as acupuncture and reflexology, while others 
used dietary modification but reported that this could be 
restrictive and difficult to maintain.
Certain foods seem to make it worse than others, and 
I’ve had a nutritionist for quite a while who, on three 
occasions, has sorted my symptoms out, but the di-
etary restrictions are so awful I end up lapsing and 
going back eating normal food again. (P9, male, 
CRSwNP)
Medical treatment options
Most participants reported using nasal steroid sprays, 
describing them as a rescue or maintenance treatment, 
which helped manage their symptoms. However, some 
reported difficulties in remembering to use regularly, 
while others stopped using the sprays if they did not see 
an improvement.
It should be a daily thing, but I’ll forget or I’ll think 
oh, I’m all right, I don’t need to take it, but maybe 
then I don’t know if it just needs to be part of a nor-
mal routine for me to do it all the time. I do miss days. 
(P19, female, CRSsNP)
Some concerns were expressed about not using the 
sprays in the correct way, resulting in the spray remaining 
in the nose and not reaching the sinuses. In some cases, 
the nurse or GP were helpful in describing or demon-
strating how to use the sprays correctly.
Now, my trouble with that is getting it into the right 
area. My doctor has kind of told me how to do it, but 
it’s awkward. It is difficult, and I’m not in any way con-
vinced that I’ve actually got it in the right area. (P9, 
Male, CRSwNP)
A number of participants reported using nasal irriga-
tion on recommendation from ENT specialists, and while 
some found it beneficial in clearing nasal passages, others 
found the technique awkward or time-consuming.
To be honest, I don’t think I would do that because 
for work days, I get up at quarter to six, and sitting 
there then with that nasal douche thing going up one 
nose and down the other, I haven’t got time for it. 
(P19, female, CRSsNP)
Most participants had some experience of antibiotics 
for their CRS, describing their potential benefits when 
symptoms were severe or when there was a possibility 
of an underlying infection. Some concerns were raised 
about associated side effects, with reports of stomach 
problems associated with some antibiotics, while others 
reported concerns about emerging antibiotic resistance.
The only thing, my concern is with the antibiotics be-
cause I know my stomach is very sensitive. I know with 
antibiotics then I have stomach problems so that’s 
why I told you that I wasn’t a fan of antibiotics. (P3, 
female, CRSsNP)
Theme 3: healthcare interactions
Primary care consultation
Participants reported consulting the GP when their 
symptoms of CRS worsened or became unmanageable 
with self-management or prescribed medical treatments. 
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However, participants often described difficulties getting 
a GP appointment.
It’s very hard to get an appointment now and our 
doctors, especially at the moment, it’s that we’re low 
on doctors and I think that that’s such a shame be-
cause you are stressed at home and you want to see 
somebody (P24, female, CRSsNP)
However, when participants do consult in primary care, 
some described not prioritising their CRS especially if 
they had other health problems. Others described not 
wanting to burden the healthcare system by booking 
multiple appointments.
But to be fair, because I’ve got a lot of other health 
problems, they kind of outweigh that, and you know 
you’re only allowed to see the doctor about one or 
two things. (P1, female, CRSsNP)
Participants often described frustration about not 
being listened to by their GPs, or the GPs being dismissive 
or disinterested in their symptoms of CRS and not under-
standing the full impact on the participants’ lives.
So that would be nice, for people, or doctors, to ac-
tually recognise that it actually is as painful as you’re 
telling them it is. (P11, female, CRSsNP)
Participants often report difficulties in seeing the same 
GP at subsequent visits which could result in a lack of 
continuity of care. Others suggested that multiple visits 
were often needed before getting the right treatment or 
onward referral.
It was a long process because you keep going back to 
the GP over a period of months and months, prob-
ably a year or so, to finally make them realise. (P22, 
male, CRSwNP)
Expectations of secondary care
Consultation in secondary care is described as important 
to understand what is causing their symptoms, especially 
if symptoms have been present for a long time.
Seeing as it has been going on for so long now, I really 
think that I should be referred to the hospital and in-
vestigated to actually see if there’s anything else going 
on up there that’s causing it. (P1, female, CRSsNP)
Participants recount undergoing a series of tests and 
examinations for the specialist to make a diagnosis of 
CRS. However, some expressed the view that specialists 
do not always take a ‘holistic’ approach to CRS especially 
if participants have asthma and allergy, and are not always 
open-minded to other causes or treatments for CRS.
I have felt sometimes specialists should be able to see 
the problem in a wider context. (P16, male, CRSwNP)
Some participants feel rushed through the consultation 
without being given time to ask questions and have them 
answered satisfactorily. Others were frustrated with the 
time between clinic appointments, and also reported a 
lack of continuity due to follow-up with different special-
ists (eg, consultants, registrars, staff grades, etc). This 
contributed to reduced satisfaction with the secondary 
care system.
I would be sent off to try something for three months 
but it would be 11 months before I saw them again. 
(p21, male, CRSwNP)
Theme 4: surgical intervention
When surgery is appropriate
Some participants described an expectation for further 
medical management when consulting the ENT specialist 
for the first time and often wanted to try additional 
medical options first prior to being considered for sinus 
surgery.
To be honest with you I haven’t really thought about 
surgery, I don’t like being put under to be honest. 
That would be my really, really, really last resort. (P11, 
female, CRSsNP)
However, others had a high expectation of surgery and 
considered surgery to be offered too late in the patient 
journey.
Yes, surgery obviously is always looked at as a final 
thing, which I disagree with because it was the best 
and the only thing for me and if they had done that 
11 months earlier I think it would have made every-
one’s life a lot easier. (P20, male, CRSsNP)
Participants were variously concerned about the risks 
associated with surgery, including the general anaes-
thetic, discomfort, and the possibility of making things 
worse. Surgery also requires time off work which was not 
always possible for participants. However, most would only 
consider surgery if it resulted in a significant improve-
ment in symptoms and was more than just a temporary 
solution.
Whilst I accept there might not be a total cure, if it 
wasn’t a very significant improvement, then frankly 
in my opinion, it probably wouldn’t be worth it. (P7, 
male, CRSsNP)
Decision-making for surgery
Participants reported relying on the ENT surgeon to 
decide whether surgery was the best option for them. 
However, participants who reported having nasal polyps 
often described being advised by the specialist for early 
surgery.
They often say, ‘Well, no, it’s your choice’, and I’m 
like, ‘Well, hang on, you are the expert… They know 
the potential benefits. I don’t, so I go with the doc-
tor and if the doctor thinks I should have surgery, I’ll 
have surgery. (P9, male, CRSwNP)
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Participants with nasal polyps described a good under-
standing of what surgery was trying to achieve; however, 
participants without polyps were less likely to understand 
the purpose of sinus surgery.
I don’t know what they could do for me, when I don’t 
have polyps and I don’t have a blockage. (P24, fe-
male, CRSsNP)
Anticipated outcomes
Sinus surgery was often described as a temporary solu-
tion, with expectation that symptoms would return and 
further surgery may be required.
I presume I’m likely to need at least one more, two, 
three more operations before my lifetime, and as and 
when the symptoms get bad then yes, I don’t really 
see there’s much choice. (P15, male, CRSwNP)
Many participants described acknowledging that there 
is no definitive answer for their CRS and recognised that 
they would require ongoing treatments to manage their 
symptoms.
I have been told that it is chronic; I have to take nasal 
sprays all the time which was a bit inconvenient for 
me. They said there’s no quick cure for it, even sur-
gery doesn’t solve the problem. (P16, male, CRSwNP)
DIsCussIOn
summary
CRS has a significant impact on patients’ quality of life, 
affecting their ability to work effectively, their social inter-
actions and daily living. Patients seek help when symp-
toms become unmanageable but can become frustrated 
with the primary care system, with difficulties obtaining 
an appointment and with lack of continuity of care. GPs 
can be perceived as being dismissive of CRS symptoms 
and patients often prioritise other concerns when they 
consult. This lack of acknowledgement and communica-
tion can result in delays in accessing appropriate treat-
ment and referral. Adherence to intranasal steroids is a 
problem and patients are often uncertain about correct 
application. Nasal irrigation can be time-consuming and 
difficult for patients to use. Secondary care consultations 
can appear rushed, and patients would like specialists 
to take a more ‘holistic’ approach, by considering CRS 
management in the wider context of the patients’ overall 
health and well-being. Surgery is often considered a 
temporary solution, appropriate when medical options 
have been explored.
Comparison with existing literature
Previous work has identified that the impact of CRS can 
range from a minor inconvenience to having significant 
implications for patients’ social activities and employ-
ment.7 14 While our study described similar effects on 
patient quality of life, it also identified that patients were 
often embarrassed and upset by their symptoms, and 
this could affect their confidence in social situations and 
ability to work effectively. Zhou et al15 found a strong asso-
ciation between sinonasal diseases and depression symp-
toms, while a study by Erskine et al16 found that depression 
and anxiety were significantly more common in patients 
with CRS compared with healthy controls. Patients in our 
study also described depression and anxiety associated 
with their sinonasal symptoms and the impact on their 
daily lives.
The chronic nature of CRS means that patients often 
accept and normalise their symptoms, and our study 
found that patients do not always prioritise CRS when 
they consult their GP, especially if they have significant 
comorbidities. However, when patients do consult, GPs 
can be dismissive or underestimate the impact of the 
symptoms. A study of 100 physicians in the USA similarly 
found that ~30% underestimated the impact of allergic 
rhinitis on patients’ ability to work,17 although it could not 
be established whether this affected treatment decisions.
Maximum benefit from medication is best achieved 
if patients use their treatments correctly and for the 
prescribed amount of time.18 Intranasal steroids are an 
important and established treatment for CRS19 20; however, 
compliance can be variable.21 Our study highlighted that 
intranasal steroid use can be suboptimal in primary care 
either due to incorrect use of nasal sprays or premature 
discontinuation of treatment. Patients described being 
uncertain about correct use and reported limited infor-
mation or training from healthcare professionals.
Nasal irrigation was only rarely used in primary care, 
while more commonly recommended by ENT surgeons. 
Patients generally found the technique time-consuming 
and uncomfortable, although some patients reported it 
to be acceptable if they were shown how to use it correctly. 
This is consistent with a recent primary care study22 which 
found nasal irrigation to be an acceptable procedure 
that could relieve symptoms in patients with recurrent 
or chronic rhinosinusitis. However, detailed and clear 
patient information, together with perseverance with 
treatment, may be required to improve uptake and usage 
over the longer term which has been shown to be poor at 
the point of referral to secondary care.21 There may be an 
important role here for pharmacists, who are accessible 
to patients for advice and support without requiring an 
appointment. Community-based pharmacists have been 
shown to significantly improve inhaler use for patients 
with lower respiratory disease, a technique which simi-
larly requires good instruction and technique training.23
Despite valuing the secondary care consultation, patients 
can become frustrated with a lack of understanding of 
their CRS symptoms, the extended time between appoint-
ments and a perceived lack of holistic approach especially 
if they had comorbidities such as asthma. These find-
ings are consistent with previous qualitative work which 
reported that CRS patients can be dissatisfied with the 
lack of an integrated approach to upper and lower respi-
ratory conditions.24 The coexistence of CRS and asthma 
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and allergic rhinitis is well documented25–27 which has 
led to the concept of a united airway disease. This may 
necessitate the use of coordinated care strategies to better 
address these different manifestations of airways disease, 
with the view to providing better overall management 
and improving patient satisfaction and compliance with 
treatment.
Patients in this study reported mixed views about sinus 
surgery for their CRS, which appeared to be related to 
previous surgical procedures, severity of symptoms, polyp 
status and effectiveness of medical treatments. Addition-
ally, many patients report wanting to explore medical 
treatment options prior to being considered for surgery. 
While other work has explored patient views about the 
impact of CRS and its management,7 this is the first study 
to specifically explore patient views of treatment options 
and referral pathways for CRS and will help to understand 
the decision-making process from the patient perspective.
Implications for practice
Patients perceive that clinicians do not always appreciate 
the severity and impact of CRS and can become dissat-
isfied with management. Better recognition of CRS and 
the impact it has on patients’ lives has the potential to 
improve early management in primary care and enhance 
the precision of referral. Patients also perceive that they 
do not get enough information and find some things 
difficult. Better communication between patients and 
clinicians and involving patient in treatment decisions 
have the potential to increase patient satisfaction and 
improve compliance with treatment options. More effi-
cient delivery of care (eg, appointment viability, reduc-
tions in clinic waiting times) also has the potential to 
improve patient-perceived barriers and causes of frustra-
tion and delay.
strengths and limitations
A key strength of this study was the recruitment of patients 
from primary, secondary and tertiary care, from urban 
and rural parts of the UK. This allowed us to capture the 
views and experiences of patients at different stages of 
their CRS journey, from a range of locations with differing 
local services and referral pathways. It would be inter-
esting to explore whether views and opinions differed 
between demographic groups, but this was not the focus 
of our evaluation.
Our sample included patients with both CRSsNP and 
CRSwNP who had experience of a range of self-manage-
ment techniques, medical and surgical interventions. 
However, it is unclear whether the demographics of 
primary care sample was similar to the non-respondent 
group. There are many reasons why patients do not 
respond to invitation letters for research; however, it 
is possible that our primary care sample represents a 
group of patients with more severe or troublesome CRS 
symptoms.
The MACRO study is situated in the UK, and it is possible 
that CRS patients’ experiences in different countries and 
healthcare systems may vary from those reported in the 
UK. Although we feel that our findings are likely to be 
relevant to countries with similar patterns of CRS manage-
ment in primary and secondary care, replication in other 
settings would be required to confirm this.
Rigorous methods were employed to ensure credibility 
and trustworthiness of the findings of this study, including 
constant comparison techniques, multiple coders and a 
transparent audit trail.
COnClusIOn
In summary, our qualitative study identified that patients 
can become frustrated with the management of their 
CRS, and impact on quality of life is not always recognised. 
Better coordinated care between general practice and 
specialist settings, with evidence-based treatment options 
and a clear, integrated care pathway, is needed to opti-
mise CRS patient management across both settings. The 
MACRO programme also included a qualitative study 
exploring primary and secondary care clinicians’ views of 
CRS management, which has recently been published.9 
These two qualitative papers should ideally be considered 
in conjunction, and their findings have helped inform 
the trial design in MACRO. Together with the trial find-
ings, they will help to formulate new recommendations 
for the management of patients with CRS across primary 
and secondary care.
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